Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 86

    1.

    Effects of intensive insulin therapy alone and with added pioglitazone on renal salt/water balance and fluid compartment shifts in type 2 diabetes.

    Mudaliar S, Chang AR, Aroda VR, Chao E, Burke P, Baxi S, Griver KA, O'Connor DT, Henry RR.

    Diabetes Obes Metab. 2009 Nov 2. [Epub ahead of print]PMID: 19889003 [PubMed - as supplied by publisher]Related articles

    2.

    Serum glucose control in diabetic patients with cardiovascular disease: should we be less aggressive?

    Mudaliar S.

    Curr Atheroscler Rep. 2009 Sep;11(5):384-90. Review.PMID: 19664383 [PubMed - indexed for MEDLINE]Related articles

    3.

    Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis.

    Reaven PD, Moritz TE, Schwenke DC, Anderson RJ, Criqui M, Detrano R, Emanuele N, Kayshap M, Marks J, Mudaliar S, Harsha Rao R, Shah JH, Goldman S, Reda DJ, McCarren M, Abraira C, Duckworth W; Veterans Affairs Diabetes Trial.

    Diabetes. 2009 Nov;58(11):2642-8. Epub 2009 Aug 3.PMID: 19651816 [PubMed - in process]Related articles

    4.

    Discontinuation of quetiapine from an NIMH-funded trial due to serious adverse events.

    Jeste DV, Jin H, Golshan S, Mudaliar S, Glorioso D, Fellows I, Kraemer H, Arndt S.

    Am J Psychiatry. 2009 Aug;166(8):937-8. No abstract available. PMID: 19651757 [PubMed - indexed for MEDLINE]Related articles

    5.

    Actos Now for the prevention of diabetes (ACT NOW) study.

    Defronzo RA, Banerji M, Bray GA, Buchanan TA, Clement S, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner R, Reaven PD, Schwenke D, Stentz FB, Tripathy D.

    BMC Endocr Disord. 2009 Jul 29;9:17.PMID: 19640291 [PubMed - in process]Related articlesFree article

    6.

    Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans.

    Phillips SA, Kung J, Ciaraldi TP, Choe C, Christiansen L, Mudaliar S, Henry RR.

    Am J Physiol Endocrinol Metab. 2009 Sep;297(3):E767-73. Epub 2009 Jul 21.PMID: 19622782 [PubMed - indexed for MEDLINE]Related articles

    7.

    Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.

    Jones MR, Mudaliar S, Hernandez-Triana E, Unnikrishnan AG, Lai YL, Abby SL, Misir S, Jin X, Nagendran S.

    Curr Med Res Opin. 2009 Sep;25(9):2239-49.PMID: 19622007 [PubMed - in process]Related articles

    8.

    Incretin therapies: effects beyond glycemic control.

    Mudaliar S, Henry RR.

    Eur J Intern Med. 2009 Jul;20 Suppl 2:S319-28. Epub 2009 Jun 21. Review.PMID: 19580951 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study.

    Henry RR, Lincoff AM, Mudaliar S, Rabbia M, Chognot C, Herz M.

    Lancet. 2009 Jul 11;374(9684):126-35. Epub 2009 Jun 8.PMID: 19515415 [PubMed - indexed for MEDLINE]Related articles

    10.

    GSK-3beta and control of glucose metabolism and insulin action in human skeletal muscle.

    Ciaraldi TP, Carter L, Mudaliar S, Henry RR.

    Mol Cell Endocrinol. 2009 Jun 6. [Epub ahead of print]PMID: 19505532 [PubMed - as supplied by publisher]Related articles

    11.

    Incretin therapies: effects beyond glycemic control.

    Mudaliar S, Henry RR.

    Am J Med. 2009 Jun;122(6 Suppl):S25-36. Review.PMID: 19464425 [PubMed - indexed for MEDLINE]Related articles

    12.

    Association of posttraumatic stress disorder with increased prevalence of metabolic syndrome.

    Jin H, Lanouette NM, Mudaliar S, Henry R, Folsom DP, Khandrika S, Glorioso DK, Jeste DV.

    J Clin Psychopharmacol. 2009 Jun;29(3):210-5.PMID: 19440072 [PubMed - indexed for MEDLINE]Related articles

    13.

    Prevalence of diabetes, metabolic syndrome, and cardiovascular risk factors in US Asian Indians: results from a national study.

    Misra R, Patel T, Kotha P, Raji A, Ganda O, Banerji M, Shah V, Vijay K, Mudaliar S, Iyer D, Balasubramanyam A.

    J Diabetes Complications. 2009 Mar 18. [Epub ahead of print]PMID: 19303333 [PubMed - as supplied by publisher]Related articles

    14.

    Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial.

    Aroda VR, Ciaraldi TP, Burke P, Mudaliar S, Clopton P, Phillips S, Chang RJ, Henry RR.

    J Clin Endocrinol Metab. 2009 Feb;94(2):469-76. Epub 2008 Nov 4.PMID: 18984667 [PubMed - indexed for MEDLINE]Related articles

    15.

    Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.

    Ciaraldi TP, Aroda V, Mudaliar S, Chang RJ, Henry RR.

    J Clin Endocrinol Metab. 2009 Jan;94(1):157-63. Epub 2008 Oct 14.PMID: 18854391 [PubMed - indexed for MEDLINE]Related articles

    16.

    Total reconstruction of the vesico-urethral junction.

    Tewari A, Jhaveri J, Rao S, Yadav R, Bartsch G, Te A, Ioffe E, Pineda M, Mudaliar S, Nguyen L, Libertino J, Vaughan D.

    BJU Int. 2008 Apr;101(7):871-7.PMID: 18321319 [PubMed - indexed for MEDLINE]Related articles

    17.

    Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin.

    Jin H, Meyer JM, Mudaliar S, Jeste DV.

    Schizophr Res. 2008 Mar;100(1-3):70-85. Epub 2008 Jan 18. Review.PMID: 18206351 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Inhaled insulin using AERx insulin Diabetes Management System (AERx iDMS).

    Mudaliar S.

    Expert Opin Investig Drugs. 2007 Oct;16(10):1673-81. Review.PMID: 17922630 [PubMed - indexed for MEDLINE]Related articles

    19.

    Inhaled insulin in patients with asthma and chronic obstructive pulmonary disease.

    Mudaliar S, Henry RR.

    Diabetes Technol Ther. 2007 Jun;9 Suppl 1:S83-92.PMID: 17563308 [PubMed - indexed for MEDLINE]Related articles

    20.

    New frontiers in the management of type 2 diabetes.

    Mudaliar S.

    Indian J Med Res. 2007 Mar;125(3):275-96. Review.PMID: 17496356 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Significant Insulin Dose Errors May Occur if Blood Glucose Results Are Obtained from Miscoded Meters.

    Raine CH, Schrock LE, Edelman SV, Mudaliar SR, Zhong W, Proud LJ, Parkes JL.

    J Diabetes Sci Technol. 2007 Mar;1(2):205-10.PMID: 19888408 [PubMed - in process]Free article

    22.

    A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial.

    McKibbin CL, Patterson TL, Norman G, Patrick K, Jin H, Roesch S, Mudaliar S, Barrio C, O'Hanlon K, Griver K, Sirkin A, Jeste DV.

    Schizophr Res. 2006 Sep;86(1-3):36-44. Epub 2006 Jul 12.PMID: 16842977 [PubMed - indexed for MEDLINE]Related articles

    23.

    Tissue-specific expression and regulation of GSK-3 in human skeletal muscle and adipose tissue.

    Ciaraldi TP, Oh DK, Christiansen L, Nikoulina SE, Kong AP, Baxi S, Mudaliar S, Henry RR.

    Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E891-8. Epub 2006 Jun 6.PMID: 16757548 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Diabetes treatments have differential effects on nontraditional cardiovascular risk factors.

    Fonseca VA, Theuma P, Mudaliar S, Leissinger CA, Clejan S, Henry RR.

    J Diabetes Complications. 2006 Jan-Feb;20(1):14-20.PMID: 16389162 [PubMed - indexed for MEDLINE]Related articles

    25.

    Efforts to improve subsequent treatment of cardiovascular risk factors in older patients with diabetes hospitalized for a cardiac event.

    Echeverry D, Dike M, Jovanovic L, Wollitzer AO, Westphal S, Mudaliar S, Washington C, Davidson MB.

    Am J Manag Care. 2005 Dec;11(12):758-64.PMID: 16336059 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Adipocyte differentiation-related protein in human skeletal muscle: relationship to insulin sensitivity.

    Phillips SA, Choe CC, Ciaraldi TP, Greenberg AS, Kong AP, Baxi SC, Christiansen L, Mudaliar SR, Henry RR.

    Obes Res. 2005 Aug;13(8):1321-9.PMID: 16129713 [PubMed - indexed for MEDLINE]Related articles

    27.

    Effects of the rapid-acting insulin analog glulisine on cultured human skeletal muscle cells: comparisons with insulin and insulin-like growth factor I.

    Ciaraldi TP, Phillips SA, Carter L, Aroda V, Mudaliar S, Henry RR.

    J Clin Endocrinol Metab. 2005 Oct;90(10):5551-8. Epub 2005 Jul 19.PMID: 16030168 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument.

    Palmer BW, Dunn LB, Appelbaum PS, Mudaliar S, Thal L, Henry R, Golshan S, Jeste DV.

    Arch Gen Psychiatry. 2005 Jul;62(7):726-33.PMID: 15997013 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists.

    Cha BS, Ciaraldi TP, Park KS, Carter L, Mudaliar SR, Henry RR.

    Am J Physiol Endocrinol Metab. 2005 Jul;289(1):E151-9. Epub 2005 Feb 22.PMID: 15727952 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Skeletal muscle GLUT1 transporter protein expression and basal leg glucose uptake are reduced in type 2 diabetes.

    Ciaraldi TP, Mudaliar S, Barzin A, Macievic JA, Edelman SV, Park KS, Henry RR.

    J Clin Endocrinol Metab. 2005 Jan;90(1):352-8. Epub 2004 Oct 13.PMID: 15483099 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus.

    Bhalla MA, Chiang A, Epshteyn VA, Kazanegra R, Bhalla V, Clopton P, Krishnaswamy P, Morrison LK, Chiu A, Gardetto N, Mudaliar S, Edelman SV, Henry RR, Maisel AS.

    J Am Coll Cardiol. 2004 Sep 1;44(5):1047-52.PMID: 15337217 [PubMed - indexed for MEDLINE]Related articles

    32.

    Combination therapy for type 2 diabetes.

    Mudaliar S, Henry RR.

    Endocr Pract. 1999 Jul-Aug;5(4):208-19.PMID: 15251678 [PubMed]Related articles

    33.

    Intense management of diabetes mellitus: role of glucose control and antiplatelet agents.

    Mudaliar S.

    J Clin Pharmacol. 2004 Apr;44(4):414-22. Review.PMID: 15051750 [PubMed - indexed for MEDLINE]Related articles

    34.

    Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp.

    Sowell M, Mukhopadhyay N, Cavazzoni P, Carlson C, Mudaliar S, Chinnapongse S, Ray A, Davis T, Breier A, Henry RR, Dananberg J.

    J Clin Endocrinol Metab. 2003 Dec;88(12):5875-80.PMID: 14671184 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    A pilot study on CD4 & CD8 cell counts in healthy HIV seronegative pregnant women.

    Dayama A, Pandit D, Mudaliar S, Bharadwaj R, Bharucha KE, Shrotri AN, Joshi S.

    Indian J Med Res. 2003 May;117:198-200.PMID: 14609046 [PubMed - indexed for MEDLINE]Related articles

    36.

    Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications.

    Mudaliar S, Chang AR, Henry RR.

    Endocr Pract. 2003 Sep-Oct;9(5):406-16. Review.PMID: 14583425 [PubMed - indexed for MEDLINE]Related articles

    37.

    Young and elderly type 2 diabetic patients inhaling insulin with the AERx insulin diabetes management system: a pharmacokinetic and pharmacodynamic comparison.

    Henry RR, Mudaliar S, Chu N, Kim D, Armstrong D, Davis TT, An B, Reinhardt RR.

    J Clin Pharmacol. 2003 Nov;43(11):1228-34.PMID: 14551177 [PubMed - indexed for MEDLINE]Related articles

    38.

    Dose-response relationships of inhaled insulin delivered via the Aerodose insulin inhaler and subcutaneously injected insulin in patients with type 2 diabetes.

    Kim D, Mudaliar S, Chinnapongse S, Chu N, Boies SM, Davis T, Perera AD, Fishman RS, Shapiro DA, Henry R.

    Diabetes Care. 2003 Oct;26(10):2842-7.PMID: 14514589 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Detection of antibodies to Brucella abortus in animal handlers.

    Mudaliar S, Bhore A, Pandit D.

    Indian J Med Sci. 2003 May;57(5):181-6.PMID: 14514248 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Reduced mechanical efficiency in chronic obstructive pulmonary disease but normal peak VO2 with small muscle mass exercise.

    Richardson RS, Leek BT, Gavin TP, Haseler LJ, Mudaliar SR, Henry R, Mathieu-Costello O, Wagner PD.

    Am J Respir Crit Care Med. 2004 Jan 1;169(1):89-96. Epub 2003 Sep 18.PMID: 14500263 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.

    Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR, Reinhardt RR.

    Diabetes Care. 2003 Sep;26(9):2598-603.PMID: 12941725 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes.

    Epshteyn V, Morrison K, Krishnaswamy P, Kazanegra R, Clopton P, Mudaliar S, Edelman S, Henry R, Maisel A.

    Diabetes Care. 2003 Jul;26(7):2081-7.PMID: 12832317 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Regulation of skeletal muscle morphology in type 2 diabetic subjects by troglitazone and metformin: relationship to glucose disposal.

    Mathieu-Costello O, Kong A, Ciaraldi TP, Cui L, Ju Y, Chu N, Kim D, Mudaliar S, Henry RR.

    Metabolism. 2003 May;52(5):540-6.PMID: 12759881 [PubMed - indexed for MEDLINE]Related articles

    44.

    Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.

    Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR.

    Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E354-62. Epub 2003 Apr 15.PMID: 12700163 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects.

    Henry RR, Mudaliar SR, Howland WC 3rd, Chu N, Kim D, An B, Reinhardt RR.

    Diabetes Care. 2003 Mar;26(3):764-9.PMID: 12610035 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy.

    Phillips SA, Ciaraldi TP, Kong AP, Bandukwala R, Aroda V, Carter L, Baxi S, Mudaliar SR, Henry RR.

    Diabetes. 2003 Mar;52(3):667-74.PMID: 12606507 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.

    Levetan C, Want LL, Weyer C, Strobel SA, Crean J, Wang Y, Maggs DG, Kolterman OG, Chandran M, Mudaliar SR, Henry RR.

    Diabetes Care. 2003 Jan;26(1):1-8.PMID: 12502651 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Insulin and insulin-like growth factor-1 action on human skeletal muscle: preferential effects of insulin-like growth factor-1 in type 2 diabetic subjects.

    Ciaraldi TP, Carter L, Rehman N, Mohideen P, Mudaliar S, Henry RR.

    Metabolism. 2002 Sep;51(9):1171-9.PMID: 12200763 [PubMed - indexed for MEDLINE]Related articles

    49.

    Intravenous glargine and regular insulin have similar effects on endogenous glucose output and peripheral activation/deactivation kinetic profiles.

    Mudaliar S, Mohideen P, Deutsch R, Ciaraldi TP, Armstrong D, Kim B, Sha X, Henry RR.

    Diabetes Care. 2002 Sep;25(9):1597-602.PMID: 12196433 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle.

    Nikoulina SE, Ciaraldi TP, Mudaliar S, Carter L, Johnson K, Henry RR.

    Diabetes. 2002 Jul;51(7):2190-8.PMID: 12086949 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...